More on ROIV

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-117.6% Growth)
- Ratings (8.7 Score)

Upcoming Events

- Earnings (11/9/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Roivant Sciences (NQ:ROIV)
Delayed: 36.49 -0.96 (2.56%)
Prev. Close $37.45  
Open$37.18 
52 Wk High$ 
52 Wk Low$ 
Day High$37.42 
Day Low$36.36 
P/E N/A  
EPS$ 
Volume8,225,442 

Friends, Peers and Foes (?): IMVT, ROIVW, ABUS, 0A3M, BGS (more...)

Oct 22, 2026 06:44 PM Form 4 Roivant Sciences Ltd. For: Oct 20 Filed by: Venker Eric
Oct 21, 2026 10:13 AM Roivant Sciences climbs on positive uveitis trial data
Oct 21, 2026 08:51 AM Roivant Sciences stock surges on positive uveitis trial data
Oct 21, 2026 07:06 AM Form 8-K Roivant Sciences Ltd. For: Oct 21
Oct 21, 2026 07:00 AM Roivant's brepocitinib meets all phase 3 endpoints in eye disease trial
Oct 21, 2026 07:00 AM Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)
Oct 21, 2026 07:00 AM Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
Oct 21, 2026 07:00 AM Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
Oct 20, 2026 05:42 PM Form 4 Roivant Sciences Ltd. For: Oct 16 Filed by: Sukhatme Mayukh
Oct 20, 2026 05:42 PM Form 4 Roivant Sciences Ltd. For: Oct 16 Filed by: Gline Matthew
View All Articles

Entities mentioned with ROIV

View All Entities